ETF Managers Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
ETF Managers Group's DGX Position: Q1 2023 in Review
ETF Managers Group increased its Quest Diagnostics (DGX) stake by 36% in Q1 2023, buying an estimated $607K and bringing the position to 15,988 shares worth $2.26M. The position accounts for 0.07% of the portfolio, ranked #145.
ETF Managers Group first reported a position in DGX in Q1 2016 and has held it in 25 quarters since. The position peaked at $3.25M in Q4 2020. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.
- ETF Managers Group held 15,988 shares of Quest Diagnostics worth $2.26M as of Q1 2023.
- ETF Managers Group bought 4,241 Quest Diagnostics shares in Q1 2023, an estimated $607K.
- Quest Diagnostics made up 0.07% of ETF Managers Group's portfolio in Q1 2023, its #145 holding.
- ETF Managers Group first reported a position in Quest Diagnostics in Q1 2016 and has held it in 25 quarters since.
- ETF Managers Group's Quest Diagnostics position peaked at $3.25M in Q4 2020.
- 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.
Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.